NCT05650047View on ClinicalTrials.gov

Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD

UnknownOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

September 9, 2022

Primary Completion Date

July 26, 2023

Study Completion Date

September 9, 2023

Conditions

Retinal Neovascularization

Trial Locations (3)

29501

RECRUITING

Palmetto Retina Center, Florence

63017

RECRUITING

Pepose Vision Institute, St Louis

02114

RECRUITING

Ophthalmic Cons. of Boston, Boston

Sponsors

Lead Sponsor

Notal Vision Inc.

All Listed Sponsors

lead

Notal Vision Inc.

INDUSTRY

NCT05650047 - Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD | Biotech Hunter | Biotech Hunter